UTAK Pain Management Plus
Lyophilized urine toxicology control for the quantitative determination of Pain Management drugs and their metabolites
100 % human urine matrix
Components:
Buprenorphine, Norbuprenorphine, Codeine, Norcodeine, Fentanyl, Norfentanyl, Hydrocodone, Norhydrocodone, Hydromorphone, Meperidine, Normeperidine, Methadone, Methadone Primary Metabolite (EDDP), Morphine, Monoacetylmorphine-6, Oxycodone, Noroxymycodone, Oxymorphone, Noroxymorphone, Tapentadol, N-Desmethyltapentadol, Tramadol, O-Desmethyl-cis-tramadol
Please note: Analyte composition and analyte concentration may vary with each LOT or instrument. Refer to the package insert of currently available lots for specific analyte and stability claims.
Art. No
-
UTAK REF 91000(5 x 5 ml)PM Plus Low (Pain Management)
-
UTAK REF 91002(5 x 5 ml)PM Plus High (Pain Management)
Stability
After production:
30 month at 2…8 °C
After reconstitution:
25 days at 2…8 °C